.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Julphar
Daiichi Sankyo
Moodys
Cipla
Harvard Business School
Boehringer Ingelheim
Fish and Richardson
Argus Health
Teva

Generated: December 12, 2017

DrugPatentWatch Database Preview

Quinapril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for quinapril hydrochloride and what is the scope of quinapril hydrochloride freedom to operate?

Quinapril hydrochloride
is the generic ingredient in two branded drugs marketed by Pfizer Pharms, Actavis Elizabeth, Actavis Labs Fl Inc, Apotex Inc, Aurobindo Pharma Ltd, Invagen Pharms, Lupin, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, and Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for quinapril hydrochloride. Twenty-three suppliers are listed for this compound. There is one tentative approval for this compound.

Pharmacology for quinapril hydrochloride

Tentative approvals for QUINAPRIL HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
u► SubscribeEQ 5MG BASETABLET;ORAL
u► SubscribeEQ 40MG BASETABLET;ORAL
u► SubscribeEQ 20MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds LtdQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL076607-004Dec 15, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL076459-002Dec 22, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Invagen PharmsQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL078457-003Aug 24, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL090800-001Jun 18, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL075504-003Aug 24, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL076694-003Dec 23, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-002Nov 19, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL076803-004Mar 2, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LupinQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL077690-004Jun 20, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL090800-002Jun 18, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: quinapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-002Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-004Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-003Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-001Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-002Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-004Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-003Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-002Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-001Nov 19, 1991► Subscribe► Subscribe
Pfizer PharmsACCUPRILquinapril hydrochlorideTABLET;ORAL019885-003Nov 19, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Teva
Harvard Business School
Novartis
US Department of Justice
US Army
Boehringer Ingelheim
Julphar
Citi
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot